[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100587058":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":22,"centralContacts":27,"locations":36,"responsibleParty":49,"collaborators":51,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":61,"eligibilityCriteria":62,"healthyVolunteers":57,"sex":63,"minAge":64,"maxAge":10,"enrollmentInfo":65,"targetDuration":10,"studyType":68,"phases":10,"briefSummary":69,"conditions":70,"keywords":72,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Pre-TB",null,"All subsequent patients aged 18 years or older, surgical candidates with curative intent, with a pathology-confirmed diagnosis of gastric adenocarcinoma, treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS of Rome from jan 2018 to november 2019",{"label":13,"type":10,"description":14,"interventionNames":15},"Post-TB","All subsequent patients aged 18 years or older, surgical candidates with curative intent, with a pathology-confirmed diagnosis of gastric adenocarcinoma, treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS of Rome from december 2019 onwards",[16],"Other: Multidisciplinary Tumor Board",[18],{"type":6,"name":19,"description":20,"armGroupLabels":21,"otherNames":10},"Multidisciplinary Tumor Board","Institution of Multidisciplinary Tumor Board for Gastric Cancer at Fondazione Policlinico Gemelli in november 2019",[13],[23],{"name":24,"affiliation":25,"role":26},"Alberto Biondi, Prof.","Fondazione Policlinico Agostino Gemelli IRCCS","PRINCIPAL_INVESTIGATOR",[28,33],{"name":29,"role":30,"phone":31,"phoneExt":10,"email":32},"Laura Antolino, MD, PhD","CONTACT","+393470409876","laura.antolino@gmail.com",{"name":34,"role":30,"phone":10,"phoneExt":10,"email":35},"Cristina Vacca","cristina.vacca@policlinicogemelli.it",[37],{"facility":5,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":40,"cosmosGeoPoint":43,"geoPoint":48,"contacts":10},"RECRUITING","Rome","IT","00168","Italy",{"type":44,"coordinates":45},"Point",[46,47],12.51133,41.89193,{"lat":47,"lon":46},{"type":50,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[52],{"name":53,"class":54},"Società Italiana di Chirurgia Oncologica SICO - ESSO affiliated","UNKNOWN","100587058","gastric-cancer-textbook-oncological-outcome-and-tumor-board-performance-100587058",false,"NCT06923449","Gastric Cancer' Textbook Oncological Outcome and Tumor Board Performance","Gastric Cancer' Textbook Oncological Outcome and Tumor Board Performance - The Experience of a High-volume Italian University Hospital","GaC-TOP","Inclusion Criteria:\n\n* pathology-confirmed diagnosis of gastric adenocarcinoma\n* age 18 years or older\n* surgical candidates with curative intent\n\nExclusion Criteria:\n\n* Endoscopic Mucosal Resection (EMR) or Endoscopic Submucosal Dissection (ESD)\n* previous EMR or ESD (salvage surgery)\n* histologies other than adenocarcinoma (no squamous cell carcinomas, GISTs, sarcomas, lymphomas, etc)\n* unsufficient staging (unclear clinical stage at diagnosis)\n* emergency presentation (obstrucetd, significantly bleeding, perforated gastric cancer)\n* synchronous tumors affecting survival\n* pregnant patients\n* age \\\u003C18years","ALL","18 Years",{"count":66,"type":67},250,"ESTIMATED","OBSERVATIONAL","The goal of this observational, no-profit, spontaneous, retrospective, monocentric study is to compare surgical and oncologic outcomes in patients affected by gastric cancer before and after the institution of the Tumor Board, a multidisciplinary weekly case discussion. The main question it aims to answer is whether the Textbook Outcome (TO) and Textbook Oncological Outcome (TOO) of patients with non-early, non-metastatic gastric cancer undergoing surgical treatment with curative intent have improved before (from January 2018 to November 2019) and after (from December 2019 onwards) the establishment of the Multidisciplinary Tumor Board (MTB) at Fondazione Policlinico Gemelli (FPG).",[71],"Stomach Neoplasm",[73,19,74,75],"Gastric Cancer","Textbook Outcome","Textbook Oncological Outcome","2025-04-04",{"date":78,"type":79},"2025-04-11","ACTUAL",{"date":81,"type":79},"2024-05-16",{"date":83,"type":67},"2025-06-30",{"name":5,"class":6},1]